Retraction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-019-0082-5, published online 06 December 2019
The authors have retracted this article. After publication, concerns were raised regarding suspected overlap in the cell images in Figs. 2 and 3. Specifically:
-
Figs. 2f and 3f (HUH-7 Scramble) appear to contain an overlapping area.
-
HepG2 Scramble in Fig. 2d and HUH-7 LV-DKK1 in Fig. 3d appear to be mirror images.
-
A part of the HUH7 Scramble image in Fig. 2d appears to be enlarged and presented as HepG2 Scramble.
-
The authors therefore no longer have confidence in the presented data.
All authors agree to this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, R., Lin, HM., Broering, R. et al. Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway. Sig Transduct Target Ther 8, 181 (2023). https://doi.org/10.1038/s41392-023-01475-8
Published:
DOI: https://doi.org/10.1038/s41392-023-01475-8
